S&P 500   4,299.70
DOW   33,666.34
QQQ   358.01
Stock market today: Asian shares mixed, with most regional markets closed after Wall St ticks higher
66,000% upside on tiny biotech? (Ad)
Can Undervalued Healthcare Stocks Add Yield To Your Portfolio?
Low Beta Stocks To Offset A Possible Hard Landing
The single greatest medical breakthrough of all time? (Ad)
5 Cheap Ways to Ride The AI Supercycle to Profits
Nursing Home REITs: The Surprise Heroes of High Yield Investing
The single greatest medical breakthrough of all time? (Ad)
3 Intriguing ETFs Trading Under $10 a Share
Energy Stocks Shine as High Oil Prices Boost Dividend Yields
S&P 500   4,299.70
DOW   33,666.34
QQQ   358.01
Stock market today: Asian shares mixed, with most regional markets closed after Wall St ticks higher
66,000% upside on tiny biotech? (Ad)
Can Undervalued Healthcare Stocks Add Yield To Your Portfolio?
Low Beta Stocks To Offset A Possible Hard Landing
The single greatest medical breakthrough of all time? (Ad)
5 Cheap Ways to Ride The AI Supercycle to Profits
Nursing Home REITs: The Surprise Heroes of High Yield Investing
The single greatest medical breakthrough of all time? (Ad)
3 Intriguing ETFs Trading Under $10 a Share
Energy Stocks Shine as High Oil Prices Boost Dividend Yields
S&P 500   4,299.70
DOW   33,666.34
QQQ   358.01
Stock market today: Asian shares mixed, with most regional markets closed after Wall St ticks higher
66,000% upside on tiny biotech? (Ad)
Can Undervalued Healthcare Stocks Add Yield To Your Portfolio?
Low Beta Stocks To Offset A Possible Hard Landing
The single greatest medical breakthrough of all time? (Ad)
5 Cheap Ways to Ride The AI Supercycle to Profits
Nursing Home REITs: The Surprise Heroes of High Yield Investing
The single greatest medical breakthrough of all time? (Ad)
3 Intriguing ETFs Trading Under $10 a Share
Energy Stocks Shine as High Oil Prices Boost Dividend Yields
S&P 500   4,299.70
DOW   33,666.34
QQQ   358.01
Stock market today: Asian shares mixed, with most regional markets closed after Wall St ticks higher
66,000% upside on tiny biotech? (Ad)
Can Undervalued Healthcare Stocks Add Yield To Your Portfolio?
Low Beta Stocks To Offset A Possible Hard Landing
The single greatest medical breakthrough of all time? (Ad)
5 Cheap Ways to Ride The AI Supercycle to Profits
Nursing Home REITs: The Surprise Heroes of High Yield Investing
The single greatest medical breakthrough of all time? (Ad)
3 Intriguing ETFs Trading Under $10 a Share
Energy Stocks Shine as High Oil Prices Boost Dividend Yields
NYSE:CINT

CI&T (CINT) Stock Forecast, Price & News

$6.30
-0.09 (-1.41%)
(As of 09/28/2023 ET)
Compare
Today's Range
$6.26
$6.42
50-Day Range
$4.75
$6.49
52-Week Range
$3.34
$10.95
Volume
180,363 shs
Average Volume
125,212 shs
Market Capitalization
$843.00 million
P/E Ratio
26.25
Dividend Yield
N/A
Price Target
$5.83

CI&T MarketRank™ Forecast

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
7.4% Downside
$5.83 Price Target
Short Interest
Healthy
2.08% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.01mentions of CI&T in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
9.37%
From $0.32 to $0.35 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.39 out of 5 stars

Construction Sector

102nd out of 103 stocks

Custom Computer Programming Services Industry

24th out of 27 stocks


CINT stock logo

About CI&T (NYSE:CINT) Stock

CI&T Inc., together with its subsidiaries, provides strategy, design, and software engineering services to enable digital transformation for enterprises and companies worldwide. It is also involved in the development of customizable software through the implementation of software solutions, including machine learning, artificial intelligence, analytics, cloud migration, and mobility technologies. The company was founded in 1995 and is headquartered in Campinas, Brazil.

CINT Price History

CINT Stock News Headlines

66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
What 4 Analyst Ratings Have To Say About CI&T
CI&T Inc. (CINT) Tops Q2 Earnings Estimates
CI&T Reports Solid Results in 2Q23
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
Earnings Preview: CI&T
Citigroup Downgrades CI&T Inc (CINT)
Here’s Why CI&T (CINT) Declined in Q1
CI&T: Q1 Earnings Insights
CI&T Reports Solid Results in 1Q23
See More Headlines
Receive CINT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CI&T and its competitors with MarketBeat's FREE daily newsletter.

CINT Company Calendar

Last Earnings
8/18/2023
Today
9/29/2023
Next Earnings (Estimated)
11/16/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Custom computer programming services
Sub-Industry
N/A
Fax
N/A
Employees
6,904
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.83
High Stock Price Forecast
$6.00
Low Stock Price Forecast
$5.50
Forecasted Upside/Downside
-7.4%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Net Income
$24.39 million
Pretax Margin
10.00%

Debt

Sales & Book Value

Annual Sales
$423.72 million
Cash Flow
$0.45 per share
Book Value
$1.94 per share

Miscellaneous

Free Float
N/A
Market Cap
$843.00 million
Optionable
Not Optionable
Beta
1.13
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Cesar Nivaldo Gon (Age 52)
    CEO & Director
  • Mr. Stanley Rodrigues (Age 52)
    Chief Financial Officer
  • Mr. Bruno Guicardi (Age 51)
    Director of Operations
  • Mr. Eduardo Galvao
    Head of Investor Relations
  • Ms. Carla Borges
    Chief People Officer
  • Mr. Leonardo Mattiazzi
    Exec. VP of Global Innovation
  • Mr. Bob Wollheim
    Chief Strategy Officer
  • Mr. Felipe Brito
    Exec. VP
  • Ms. Solange Sobral
    Exec. VP of Operations Europe
  • Mr. Amin Nunes
    Exec. VP of Growth & Innovation Latam













CINT Stock - Frequently Asked Questions

Should I buy or sell CI&T stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CI&T in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CINT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CINT, but not buy additional shares or sell existing shares.
View CINT analyst ratings
or view top-rated stocks.

What is CI&T's stock price forecast for 2023?

3 analysts have issued twelve-month price objectives for CI&T's stock. Their CINT share price forecasts range from $5.50 to $6.00. On average, they predict the company's stock price to reach $5.83 in the next year. This suggests that the stock has a possible downside of 7.4%.
View analysts price targets for CINT
or view top-rated stocks among Wall Street analysts.

How have CINT shares performed in 2023?

CI&T's stock was trading at $6.50 at the beginning of 2023. Since then, CINT shares have decreased by 3.1% and is now trading at $6.30.
View the best growth stocks for 2023 here
.

Are investors shorting CI&T?

CI&T saw a increase in short interest in September. As of September 15th, there was short interest totaling 381,200 shares, an increase of 53.4% from the August 31st total of 248,500 shares. Based on an average daily trading volume, of 164,300 shares, the short-interest ratio is presently 2.3 days. Approximately 2.1% of the shares of the company are short sold.
View CI&T's Short Interest
.

When is CI&T's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 16th 2023.
View our CINT earnings forecast
.

How were CI&T's earnings last quarter?

CI&T Inc (NYSE:CINT) posted its quarterly earnings data on Friday, August, 18th. The company reported $0.09 earnings per share for the quarter, beating analysts' consensus estimates of $0.08 by $0.01. The firm had revenue of $115.54 million for the quarter, compared to analyst estimates of $116.56 million. CI&T had a net margin of 7.29% and a trailing twelve-month return on equity of 19.35%.

What guidance has CI&T issued on next quarter's earnings?

CI&T issued an update on its third quarter 2023 earnings guidance on Friday, August, 18th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $101.55M-, compared to the consensus revenue estimate of $123.51 million.

When did CI&T IPO?

(CINT) raised $235 million in an IPO on Wednesday, November 10th 2021. The company issued 13,043,478 shares at a price of $17.00-$19.00 per share.

What is CI&T's stock symbol?

CI&T trades on the New York Stock Exchange (NYSE) under the ticker symbol "CINT."

How do I buy shares of CI&T?

Shares of CINT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CI&T's stock price today?

One share of CINT stock can currently be purchased for approximately $6.30.

How much money does CI&T make?

CI&T (NYSE:CINT) has a market capitalization of $843.00 million and generates $423.72 million in revenue each year. The company earns $24.39 million in net income (profit) each year or $0.24 on an earnings per share basis.

How many employees does CI&T have?

The company employs 6,904 workers across the globe.

How can I contact CI&T?

The official website for the company is www.ciandt.com. The company can be reached via phone at 55-19-2102-4500 or via email at investors@ciandt.com.

This page (NYSE:CINT) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -